99mTc-sestamibi and 18F-fluorodeoxyglucose imaging in patients with cardiogenic shock: A pilot study

99mTc-sestamibi and 18F-fluorodeoxyglucose imaging in patients with cardiogenic shock: A pilot study

BackgroundWhether perfusion/metabolism imaging differs between matched ST-segment elevation myocardial infarction (STEMI) patients with and without cardiogenic shock (CS) remains unknown.MethodsSeventeen STEMI patients with CS (13 men, 60 ± 12 years) and 16 matched STEMI patients without CS (15 men,...

Full description

Bibliographic Details
Main Authors: Cuncun Hua, Qizhe Cai, Xiao-Ying Xi, Mingming Lin, Li Wang, Lina Li, Dandan Yao, Xiaoyan Liu, Lei Zhao, Lefeng Wang, Pixiong Su, Boqia Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardiogenic shock
ST-segment elevation myocardial infarction
perfusion
fluorodeoxyglucose
major adverse cardiac events
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1047577/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1047577/full

Similar Items